论文部分内容阅读
受仿制药影响,自身免疫疾病和炎症药物市场波动明显。通过对比正在进行和计划启动的临床试验与已经完成或终止的临床试验,可以了解制药企业在这一领域的进退。对产品管线和研发项目的深入研究可进一步洞悉这一领域的主要制药企业所采用的战略措施。来自Trialtrove的报告深入分析临床研究动向、战略措施以及自身免疫疾病和炎症药物领域的制药公司如何应对多变的研发计划。
Affected by generic drugs, autoimmune diseases and inflammatory drugs market volatility. By comparing the ongoing and planned start-up clinical trials with completed or discontinued clinical trials, you can understand the pharmaceutical companies in this area retreat. In-depth research into product pipelines and R & D projects provides further insight into the strategic measures employed by major pharmaceutical companies in this area. The report from Trialtrove provides an in-depth analysis of trends in clinical research, strategic measures, and how pharmaceutical companies in the area of autoimmune diseases and inflammatory drugs respond to changing research and development programs.